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The authors report the following error in data analysis: Figure 3 shows the postoperative physical
activity of the patients using an accelerometer to quantify their recovery from surgery. The data
pertaining to all patients in one of the participant hospitals who received the a-VATS approach are
inaccurate. All a-VATS results have been removed from the revised Figure 3. As a result, the authors
can no longer conclude that a significant difference exists in the recovery times between the a-VATS
and c-VATS groups. The significant difference in the recovery times between the c-VATS and open
thoracotomy groups remains valid. All other results from the study remain accurate.
Revised Figure 3. Comparison of the postoperative physical ability as determined by Active Tracer and expressed
as the percentage of the preoperative 24-hour value. Time points included are before surgery and 0, 1, 2, 3, 4, 5,
and 6 days postoperatively. Each value represents the mean  standard error at each time point. *P < .05 for
complete VATS (c-VATS) versus open thoracotomy on postoperative days 2 to 5.
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